Unifying scientists, data, and AI agents across the entire oncology pipeline — from CRISPR design to mRNA validation to clinical translation.
Cancer research teams juggle disconnected tools for CRISPR editing, single-cell analysis, literature review, and clinical data. Critical context is lost at every handoff.
One central core. Multiple specialized agents. Continuous shared context flowing seamlessly from sequence to hypothesis to validation.
Literature mining, target identification, and sequence analysis
Guide RNA design, editing efficiency, and mRNA optimization
Cell clustering, marker genes, and transcriptomic analysis
Tumor antigen prediction and immunogenicity scoring
Real-time literature synthesis and biological knowledge graphs
Trial matching, patient stratification, and translational evidence
Search literature and analyze findings across PubMed, preprints, and patents. Dynamic biological knowledge graphs update in real-time.
Cell clustering and marker gene identification. Automated quality control, dimensionality reduction, and cell type annotation.
gRNA design and off-target analysis with editing efficiency scoring. PAM identification and guide optimization for cancer targets.
Tumor antigen prediction driving immune targeting and vaccine design. MHC binding prediction and immunogenicity scoring.
Codon optimization, stability prediction, and immunogenicity assessment. UTR design and delivery vehicle matching.
Cross-role orchestration with persistent memory across the discovery lifecycle. Agents collaborate, not compete.
No tool switching. No context loss. Every stage informs the next in a unified pipeline.
Sequence ingestion
Clustering & markers
gRNA & off-target
Tumor antigen pred
Optimization
Validation
In silico testing
Clinical translation
Wet-lab protocol
sequence → hypothesis → experiment → validation → translation
Most platforms automate a step. Farspeak coordinates the entire scientific lifecycle for enterprise teams.
An AI system orchestrating roles across your team, not another point solution to integrate. Built for enterprise biotech from day one.
Active agents reasoning live across pipelines — not retrospective dashboards. Your data works while you sleep.
From wet-lab through clinical translation in a single shared context. No more copy-pasting between CRISPR tools and trial databases.
Models compound from your experiments, literature, and operational data. The platform gets smarter with every project.
Every workflow improves the orchestration models across your organization.
Accumulated experimental and operational signal others cannot replicate.
Embedded across the entire research lifecycle — not a swappable tool.
Native hooks into wet-lab, computational, and clinical infrastructure.
Built for biotech leadership measuring real timeline and capital impact. Farspeak delivers measurable returns across the R&D organization.
Target-to-candidate acceleration through coordinated intelligence
No more dedicated data integration headcount
More viable drug targets per research cycle
Accelerated patent filing and competitive positioning
"Farspeak reduced our target validation cycle from 8 months to under 5."
Currently working with select enterprise biotech and research teams. Request early access to transform your R&D pipeline.